Competent Cells Market

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Competent Cells Market contains market size and forecasts of Competent Cells in Global, including the following market information:

Global Competent Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Competent Cells market was valued at 2046.6 million in 2021 and is projected to reach US$ 3763.3 million by 2028, at a CAGR of 9.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemically Competent Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Competent Cells include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Competent Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Competent Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Competent Cells Market Segment Percentages, by Type, 2021 (%)

Chemically Competent Cells

Electrocompetent Cells

Global Competent Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Competent Cells Market Segment Percentages, by Application, 2021 (%)

Subcloning & Routine Cloning

Phage Display Library Construction

Toxic/Unstable DNA Cloning

High-Throughput Cloning

Protein Expression

Mutagenesis

Single-Stranded DNA Production

Bacmid Creation

Cre-Lox Recombination (PIR1/PIR2)

Global Competent Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Competent Cells Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Competent Cells revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Competent Cells revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Delphi Genetics

IBA GmBH

Cell Applications

BioDynamics Laboratory

Scarab Genomics

GCC Biotech

SMOBIO Technology

Edge BioSystems